GlassScriptPhysician profile
Walter Ifeadike
NPI 1689684839
$1,251.46
in general payments reported to CMS, 2019-2025
19 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $372 · 2022: $235 · 2023: $213 · 2024: $159 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $171.55 | 2021-2025 | Gattex, Eohilia |
| Genzyme Corporation | $160.57 | 2019-2025 | |
| Alcresta Therapeutics, INC. | $107.55 | 2022-2024 | Relizorb |
| Pfizer INC. | $77.43 | 2019 | |
| Qol Medical, LLC | $60.29 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $54.65 | 2023-2024 | Exparel |
| Alnylam Pharmaceuticals INC. | $46.35 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $41.32 | 2022-2023 | Triptodur |
| Janssen Biotech, INC. | $39.53 | 2024-2025 | Tremfya, Stelara |
| Capsovision, INC. | $30.77 | 2023-2025 | Capsocam Plus |
| Sequel Med Tech, LLC | $27.69 | 2025 | Twiist |
| Ultragenyx Pharmaceutical INC. | $27.09 | 2022 | |
| Novo Nordisk INC | $24.73 | 2023 | |
| Hologic Sales and Service, LLC | $20.68 | 2023 | Coolseal Generator |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $19.51 | 2019 | |
| Endo Pharmaceuticals INC. | $18.87 | 2023 | Supprelin |
| Amgen INC. | $13.78 | 2022 | |
| Sobi, INC | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Ifeadike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.